The Connective IssueThe Fascia Institute & Treatment Center Journal
A weekly report from the line of scrimmage of fascia medicine — where grit, recovery, and getting back in the game meet.
Everybody wants the shortcut.
Every locker room has that one guy with a “secret” that’ll heal you twice as fast. This week we’re looking hard at the one everybody’s asking about — and being honest about what the science does and doesn’t say.
The peptides BPC-157 and TB-500 have gone from bodybuilding forums to mainstream conversation, sold as recovery in a vial. There’s real signal in the research — and a lot of hype riding on top of it. As a physician, my job isn’t to cheer or to scold; it’s to tell you where the line between the two actually is. That’s our cover story.
Then a genuinely proud moment: hypermobility — and our work on it — landed in HuffPost, national coverage of a condition that spends years getting dismissed as “just being flexible.” And on special teams, something new at FIT Therapeutics that most people never talk about but that quietly decides a lot of games: the pelvic floor, and a non-invasive way to train it.
Three stories, one theme: the real edge isn’t a shortcut — it’s knowing what’s actually going on. Let’s kick off.
In This Issue
- BPC-157 & TB-500: What the Peptide Hype Gets Right — and Wrong Highlight Reel
- Hypermobility Makes HuffPost The Playbook
- Pelvic Floor, Meet PEMF Special Teams
- Find the Source Before the Shortcut Two-Minute Drill
BPC-157 & TB-500: recovery in a vial?
Two peptides have become the most-asked-about recovery aids of the year. The interest is understandable — and the honest picture is more complicated than either the hype or the panic would have you believe.
A peptide is just a short chain of amino acids — a small protein-like signal the body uses to tell tissue what to do. BPC-157 is a synthetic version of a fragment found in a protein in the stomach; in laboratory and animal studies it appears to support local healing and the growth of new blood vessels at an injury site. TB-500 is a synthetic form of a fragment of thymosin beta-4, a molecule involved in cell migration and broader soft-tissue repair. On paper, that combination — local repair plus system-wide signaling — is exactly why the tendon, muscle, and fascia world is paying attention.
BPC-157 — the local worker
Studied for its apparent effect on tendon, ligament, and gut-lining repair and on new blood-vessel growth at the site of injury. Most of the encouraging data is preclinical — cells and animals — not large human trials.
TB-500 — the systemic signal
A synthetic thymosin beta-4 fragment linked to cell migration and broader soft-tissue regeneration. Popular with athletes for “whole-body” recovery — again, largely on the strength of animal work rather than robust human evidence.
Here’s where a physician has to be straight with you. For all the promise, there are no large, high-quality human trials proving these peptides safely do what the marketing claims. Neither is FDA-approved for healing injuries or boosting recovery, so essentially all use is off-label — and the regulatory ground is actively shifting. In 2026 the FDA has been reworking which peptides pharmacies may compound, with TB-500 among those under formal review. Translation: the rules around who can legally prepare and provide these are in flux right now.
The careful version
The biggest real-world risk usually isn’t the peptide itself — it’s the source. A large share of what’s sold online comes from “research-only” vendors with no oversight of purity, dosing, or sterility, and injecting an unknown compound is a genuine hazard. If peptides are worth considering at all, it’s only under a physician who knows your history, uses a legitimate pharmacy source, and treats them as one possible adjunct — never a substitute for figuring out what’s actually wrong. Please don’t order these off the internet and self-inject.
Our view is neither “miracle” nor “stay away.” It’s that a recovery aid only makes sense once you know precisely what you’re trying to repair — which is why we start with diagnostic ultrasound and Fascial Mapping™, not a prescription pad. Fix the diagnosis first; then, and only then, talk about whether anything — peptides included — helps the healing.
BPC-157 and TB-500 are not FDA-approved for treating injuries or enhancing recovery, and are not a substitute for diagnosis and appropriate care. Do not obtain or self-administer peptides without a qualified physician. Educational information only, not medical advice.
Hypermobility makes HuffPost.
A condition that spends years being waved off as “you’re just flexible” got national attention this month — with Dr. Courseault interviewed as the expert helping readers make sense of it.
HuffPost sat down with Dr. Courseault for a feature on hypermobility, and he walked readers through what he sees in the clinic every week. That matters more than a byline. For a huge number of people, being “double-jointed” isn’t a party trick — and, as he explained, it often comes bundled with chronic pain, joints that slip or dislocate, fatigue, and symptoms that reach well beyond the joints. Too often it takes years, and a stack of dismissive appointments, before anyone names it.
The lens Dr. Courseault brought to the piece
What he emphasized is where hypermobility actually lives: the connective tissue — the collagen and fascia that are supposed to give joints their stability. That’s the lens he brings in clinic: rather than treating one cranky joint at a time, he assesses how the whole soft-tissue system holds together, using ultrasound to see how tissue actually moves and load-shares. It’s also why his team has invested in research — including their published work on folate-dependent hypermobility — to understand why some bodies are built this way.
National coverage won’t fix anyone’s joints. But it shortens the distance between “something is wrong and no one believes me” and “here is a name, and here is a plan” — and that distance is where a lot of suffering hides.
Media coverage is for awareness only and is not medical advice. Hypermobility and Ehlers-Danlos syndrome require individual clinical evaluation and diagnosis.
Pelvic floor, meet PEMF.
It’s the unit nobody talks about and everybody relies on. When the pelvic floor is weak, it shows up as leaks, instability, and core problems that no amount of crunches will fix — and there’s now a way to train it without a single Kegel.
New at FIT Therapeutics in New Orleans: PEMF pelvic floor therapy — pulsed electromagnetic field therapy, a non-invasive treatment that uses pulsed electromagnetic fields to trigger thousands of deep pelvic-floor muscle contractions in a single session, far more than anyone could do voluntarily. You stay fully clothed and simply sit; the technology does the work the muscles usually can’t reach on their own.
The fascia connection is the whole point. The pelvic floor isn’t just muscle — it’s a hammock of muscle and fascia that supports the organs, stabilizes the core, and ties into the way the whole trunk moves. Strengthen it, and you’re not just chasing one symptom; you’re restoring a foundation the rest of the body depends on.
- Leaks with a cough, laugh, sneeze, or workout — the classic sign of stress incontinence.
- Postpartum recovery — rebuilding pelvic-floor strength and core stability after childbirth.
- Urgency and frequency — the “gotta-go-right-now” pattern that reshapes your day.
- Core and low-back instability — when the deep foundation isn’t holding, everything above it compensates.
- Men, too — pelvic-floor weakness isn’t only a women’s issue, including after prostate procedures.
It’s comfortable, there’s no downtime, and it pairs naturally with the fascia-focused care FIT Therapeutics is built around. If the pelvic floor has been quietly costing you — on the field, at the gym, or just getting through the day — this is a straightforward place to start.
Individual results vary. PEMF pelvic floor therapy is not appropriate for everyone — a clinical evaluation determines whether it’s right for you. Educational information only, not medical advice.
Find the source before the shortcut.
Peptides, gadgets, the next big thing — none of it works if you’re treating the wrong target. The first move is always the same: find out where the problem actually lives.
That’s what Fascial Mapping™ is for — a high-resolution ultrasound diagnostic that watches your tissue while it moves and pinpoints exactly where fascia and nerves are restricted, even when other imaging reads “clean.” Get the diagnosis right, and every decision after it — including whether anything like a peptide belongs in the plan — gets easier.
Missed last week? Catch up on the Gridiron run — “is it sciatica or your glutes,” Kendall Hagedorn’s signing with the Brewers, and the letter from Argentina on folate and EDS.